Wiadomości Polska Biznes i finanse SOPHARMA AD (3/2023) Sales revenues for December 2022
Biznes i finanse

SOPHARMA AD (3/2023) Sales revenues for December 2022

Podstawa prawna: art. 56. 1. 2 of Act on Public Offering.

„Sopharma” AD (the Company) notifies that for December 2022 the Company recorded an increase in sales of 19% compared to the same month of the previous year, incl. 14% increase in domestic sales and 21% increase in export sales.

Więcej na: http://biznes.pap.pl/pl/reports/espi/all,0,0,0,1

kom espi zdz


Pochodzenie informacji: pap-mediaroom.pl

Exit mobile version